Platelet glycogen synthase kinase 3β regulates plasma β amyloid and phosphorylated tau levels in chronic kidney disease patients with cognitive dysfunction; therapeutic role of erythropoietin

• Váldodahkkit: Vinothkumar Ganesan (Dahkki), Krishnakumar Sethuraman (Dahkki), Sureshkumar Sureshkumar (Dahkki), Venkataraman Prabhu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Society of Diabetic Nephropathy Prevention, 2023-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction: Patients with chronic kidney disease (CKD) have increasingly been diagnosed with cognitive impairment. Glycogen synthase kinase 3β (GSK3β) is directly causing both phosphorylated tau (pTau) and amyloid β (Aβ) accumulation in Alzheimer's disease (AD). GSK3β expression is more abund...